RHYTHM PHARMACEUTICALS, INC. — Form D/A
RHYTHM PHARMACEUTICALS, INC. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2015-12-10. The offering totals $40.0M, of which $40.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-12-10
- Form: D/A
- Accession: 0001140361-15-044190
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $40.0M
- Investors: 12
- Date of first sale: 2015-08-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245580
Issuer
- Name: RHYTHM PHARMACEUTICALS, INC.
- CIK: 0001649904
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 500 BOYLSTON STREET, BOSTON, MA, 02116
- Phone: 857-264-4280
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Keith Gottesdiener | Director | Burlington, MA |
| Keith Gottesdiener | Executive Officer | Burlington, MA |
| Keith Gottesdiener | Promoter | Burlington, MA |
| Neil Exter | Director | Boston, MA |
| Jonathan T Silverstein | Director | New York, NY |
| DAVID P MEEKER, M.D. | Director | CAMBRIDGE, MA |
| David J McGirr | Director | Greenwich, CT |
| Christophe Jean | Director | Slough, X0 |
| Bart T Henderson | Executive Officer | Boston, MA |
| Bart T Henderson | Promoter | Boston, MA |
| Todd T Foley | Director | Boston, MA |
| Jean Christophe | Director | Slough, X0 |
| Edward T Mathers | Director | — |
Other filings by this issuer (2)
More